Publications
-
Title & Authors Journal Publication Date

Attenuating ETEC virulence using a heat-labile enterotoxin-blocking binding protein.


Petersson M, Pettersen JS, Henriksen HB, Duzs Á, Fernández-Quintero ML, Burlet NJ, Mojica N, Krengel U, Jenkins TP, Ward AB, Andersen TE, Møller-Jensen J, Gram L, Laustsen AH, Thrane SW.
Gut Microbes Dec. 31, 2026

Bacterial enteric pathogens are major contributors to the global burden of diarrheal diseases and the associated consequences for human health including malnutrition, growth stunting, morbidity, and mortality. While mortality from diarrhea has decreased, incidence remains high, and better interventions for preventing disease are needed. Single-domain antibodies (i.e., VHHs), functioning as target-binding proteins in the gastrointestinal tract, have been proposed as a potential approach to mitigate bacterial pathogenesis. Here, we describe a mitigation strategy where precision binding of a bivalent VHH to the receptor-binding B-pentamer of heat-labile enterotoxin aggregates the AB5 toxin and impairs enterotoxigenic Escherichia coli colonization in a flow chamber model simulating the human intestine. The VHH construct also binds to the structurally similar cholera toxin and effectively abrogates its intestinal cell cytotoxicity in vitro. Based on these results, we believe that targeting virulence could emerge as a new strategy for the management of bacterial enteric pathogens, supporting gut health in at-risk populations alongside vaccination campaigns or in populations without access to vaccines.

Publisher Correction: The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies.


Klasse PJ, Sanders RW, Ward AB, Wilson IA, Moore JP.
Nat Rev Microbiol Sept. 10, 2026

Engineered antibodies preserve structural and functional recognition of Plasmodium falciparum circumsporozoite protein.


Jain M, Agrawal S, Cannac F, González-Páez GE, Lee WH, Moskovitz R, Ketchem RR, Williams KL, Emerling DE, Ward AB, Wilson IA.
Protein Sci Sept. 1, 2026

Serum IgA proteomics reveals clonal composition and neutralization of dimeric and monomeric IgA repertoires against human norovirus.


Park J, Jo G, Reyes Y, Pickens W, Kim DS, Beaver A, Costantini VP, Liu C, Kim D, Park D, Longo V, Brewer-Jensen PD, Mallory ML, Satterwhite E, Zapata-Bustos R, Marchioni J, Zweigart MR, Flitter BA, Vinjé J, Han J, Ross TM, Lee J, Lavinder JJ, Tucker SN, Ke Z, Ward AB, Lindesmith LC, Baric RS, Georgiou G.
Proc Natl Acad Sci U S A Aug. 25, 2026

A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability.


Erasmus MF, Bedinger D, Hopkins E, Ferguson G, Strickler J, Graff CP, Summers SR, Capehart SL, Slocum JD, Richardson C, Kumar S, Sun Z, Shang Y, Zhang J, Gu M, Yi L, Wellner A, Zheng S, Lu W, Sormanni P, Greenig M, Zhang H, Mann BT, Baghbanzadeh M, Rahnavard A, Moore GL, Sun H, Ding Y, Nisthal A, Kanodia J, Bernett MJ, Pélissier A, Shao Y, Rodriguez Martinez M, Ramesh K, Nastri H, Evers A, Abdelatif A, Bordner AJ, Bordyuh M, Heo L, Kidd BA, Serhat Tetikol H, Wei S, Shin JE, Peckner R, Manley L, Lunge A, Devasurmutt Y, Guloglu B, Copoiu L, McGibbon M, Fernandez-Quintero ML, Mishra N, Callaghan SM, Swanson OM, Bader DLV, Ferguson JA, Raghavan SSR, Nemoz B, Maillie CA, Bowman C, Briney B, Ward AB, Marcatili P, Akbar R, He B, Wu F, Yao J, Hu B, Kucer M, Gibson KR, Somasundaram R, Hung LW, Kaszuba T, Fremont DH, Jeong H, Kurella VB, Malhotra S, Kumar S, Liu Y, Xu L, Misa J, John ANS, Vogt J, Dávila-Hernández FA, Xu D, Chungyoun M, Huggan ZD, Gray JJ, Parkinson J, Ko YS, Wang W, Geiger F, Ziegler JD, Haas N, Challacombe C, Qamar A, Singh A, Tang YC, An Z, Jiang X, Kim Y, Zhao X, Swanson E, Klattig J, Winkler K, Bataa T, Sandig V, Denzler L, Liu C, Brezski RJ, Spector L, Perea-Schmittle K, D'Angelo S, Ferrara F, Bradbury ARM.
Nat Biotechnol Aug. 19, 2026

Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection.


Williams BG, Barrett JR, Scott JB, Rigby CA, Cagiada M, Quinkert D, McHugh K, Huhn A, Burnap SA, Gourjault C, Byrne F, Raghavan SSR, Rodrigues A, Bergamaschi L, Balzarotti B, Watson S, Miller N, King LDW, Donnellan FR, Gladstone CA, Paterson J, Scalabrino S, Silk SE, Salkeld J, Minassian AM, Skinner K, Struwe WB, Deane CM, Reece ST, Ward AB, Draper SJ.
Immunity Aug. 11, 2026

Protective pan-betacoronavirus neutralizing antibodies by vaccination.


Zhou P, Feng Z, He WT, Zhu Y, Yuan M, Li X, Zhang Y, Vo L, Capozzola T, Callaghan S, Mishra N, Avillion G, Dueker K, Liang B, Roy Chowdhury R, Nedellec R, Lee WH, Allen JD, Walsh A, Melo M, McAnarney ET, Kumar NA, Rinaldi W, Ferguson M, Crispin MM, Ward AB, Irvine DJ, Alameh MG, Weissman D, Baric RS, Gralinski LE, Wilson IA, Burton DR, Andrabi R.
bioRxiv Aug. 7, 2026

Replaying germinal center evolution on a quantified affinity landscape.


DeWitt WS, Vora AA, Araki T, Galloway JG, Alkutkar T, Bortolatto J, Castro TBR, Dumm W, Jennings-Shaffer C, Jia T, Mesin L, Ozorowski G, Pae J, Ralph DK, Bloom JD, Nourmohammad A, Song YS, Ward AB, Starr TN, Matsen FA 4th, Victora GD.
Cell Aug. 6, 2026

Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases.


Walker SM, Loutan AJ, Tchesnokov EP, Kocincova D, Gordon CJ, Escobedo RA, Jackson N, Vogel OA, Morsheimer K, Park S, Gharpure A, Urbano I, Heacock M, Chen Z, Pathak K, Wolff KC, Huerta L, Bakowski MA, Riva L, Gupta AK, Yu C, Das K, Martinez-Sobrido L, Basler CF, Davey R, Wilson IA, Ward AB, Chanda S, Chatterjee AK, Götte M.
J Biol Chem Aug. 1, 2026

Vaccination elicits HIV broadly neutralizing antibodies in primates.


Steichen JM, Madden PJ, Flynn CT, Phulera S, Shil M, Kalyuzhniy O, Liguori A, Kifude C, Sewall LM, Cottrell CA, Ma KM, Baboo S, Diedrich JK, McKenney K, deCamp AC, Carnathan DG, Phung I, Ramezani-Rad P, Marina-Zárate E, Freeman B, Xie Z, Lee JH, Sincomb T, Phelps N, Lu D, Goodwin D, Tingle R, Adachi Y, Alavi N, Tran J, Tran AS, Nascimento A, Sovie C, Bader DLV, Voic H, Zhou X, Pixton G, Walsh A, Melo MB, Schiffner T, Batista FD, Burton DR, Irvine DJ, Paulson JC, Yates JR 3rd, Ozorowski G, Ward AB, Silvestri G, Crotty S, Schief WR.
Nature Aug. 1, 2026

Structure-based design of stable recombinant hepatitis C virus E1E2 heterodimers.


Capella-Pujol J, Mulder F, Cannac F, Peters S, Newby ML, Poniman M, Zon I, Olijhoek W, Beaumont T, Crispin M, Ward AB, Schinkel J, Sanders RW, Sliepen K.
Nat Commun July 23, 2026

Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models.


Lin HK, Blake DA, Freeman R, Chen Y, Kim J, Johnson AM, Wells K, Mudigonda A, Liu W, Yadav P, Zeng F, Muhuri A, Min K, Sarkar S, Wang Y, Goyal S, Roberts RC, Christensen E, Ward AB, Heller B, Chun P, Dougan J, Porter CC, Barwick BG, Paulos CM, Yang L, Patgiri A, Thomas SN, Waller EK, Rafiq S.
Sci Transl Med July 22, 2026

Structural basis of membrane engagement and polyreactivity control in HIV-1 MPER broadly neutralizing antibodies.


Cho SY, Rantalainen K, Ozorowski G, Lu D, Tingle R, Lee WH, Ward AB, Schief WR, Wilson IA.
Proc Natl Acad Sci U S A July 21, 2026

The membrane distal domain of CD16a allosterically regulates NK cell ADCC.


Cid T, Fernandez-Quintero M, Fatima H, Robinson E, Christenson B, Loeffler J, Leaman D, Lin R, Xu K, Matthias J, Henderson SC, Spencer K, Jardine J, Zwick MB, Ward AB, Mace EM, Murin CD.
bioRxiv July 6, 2026

Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite protein.


Naghizadeh M, Flores-Garcia Y, Moskovitz R, Erdogan SM, Martin GM, Ofori EA, Plieskatt J, Cannac F, MacGill RS, Nielsen MA, Locke E, King CR, Miura K, Birkett A, Soisson LA, Sander AF, Skogstrand K, Barfod L, Salgado-Jimenez B, Borbye-Lorenzen N, Wilson IA, Ward AB, Zavala F, Theisen M.
NPJ Vaccines July 3, 2026

Heterologous betacoronavirus spike immunization in non-human primates elicits antibodies that neutralize both sarbeco- and merbecoviruses.


Dueker K, Capozzola T, Feng Z, Lin RN, Hurtado J, Bangaru S, Yuan M, Beutler N, Garcia E, He WT, Callaghan S, Avillion G, Vo L, Li X, Torres JL, Musharrafieh R, Song G, Mishra N, Sharma P, Yong P, Anzanello F, Kaczmarek Michaels K, Ben-Akiva E, Silva M, Melo M, Makhdoomi M, Westfall-Gomez E, Rinaldi W, Ferguson M, Safonova Y, Crotty S, Irvine DJ, Rogers T, Ward AB, Briney B, Wilson IA, Burton DR, Andrabi R.
Cell Rep June 23, 2026

Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144.


Pallerla S, Uplekar S, Boldog F, Paulson JC, Baboo S, Yates JR, Lee WH, Ozorowski G, Allen JD, Crispin M, Cottrell C, Ward AB, Sitaraman V, Broderick T, Costakes A, McCombs N, Ryan D, Wolfe L, Craig D, Syvertsen K, Price AE, Steichen JM, Schief WR.
bioRxiv June 16, 2026

mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a lethal mouse challenge model.


Skelly AN, Fan C, Keeffe JR, Ökten AB, Gavor E, Newby ML, Allen JD, Kreider EF, Ding W, Osbaldeston RA, Park Y, Connell AJ, Lituchy MG, Bibollet-Ruche F, Radford KM, P West A Jr, Peña-Hernández MA, Cruickshank K, Liu W, Li Y, Albertus A, McWilliams B, Russell RM, Konrath KM, Torres JL, Yuan M, Gao H, Montefiori DC, Saag MS, Goepfert PA, Kulp DW, Ward AB, Wilson IA, Shaw GM, Andrabi R, Crispin M, Weissman D, Wilen CB, Bjorkman PJ, Hahn BH.
Proc Natl Acad Sci U S A June 16, 2026

The SLC15A4-LAMTOR1 interaction licenses endolysosomal TLR-mediated mTOR signaling and inflammatory cytokine production.


Chiu TY, Hall PR, Lazar DC, Kim AS, Forli S, Ward AB, Teijaro JR, Parker CG.
bioRxiv June 9, 2026

Structural basis for conserved and distinct antigen recognition by a lineage of malaria-protective antibodies.


Jain M, Cannac F, Agrawal S, Lee WH, Loeffler JR, Fernández-Quintero ML, González-Páez GE, Moskovitz R, Ward AB, Wilson IA.
PLoS Pathog June 1, 2026
-
Title & Authors Journal Publication Date